Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
non-small cell lung cancer
Biotech
Gilead draws up $20M pact with cancer biotech Cartography
Gilead is paying $20 million to partner with Cartography Biosciences and navigate drug discovery for triple-negative breast cancer and adenocarcinoma.
Gabrielle Masson
May 28, 2024 10:26am
AstraZeneca-Daiichi's Dato-DXd didn't prove OS benefit in ph. 3
May 28, 2024 7:06am
Jacobio's KRAS data tee up safety-focused lung cancer pitch
May 1, 2024 7:01am
Ultimovacs lays off 40% in wake of cancer vaccine's phase 2 fail
Apr 17, 2024 8:22am
Eli Lilly axes next-generation, resistance-busting RET inhibitor
Feb 6, 2024 7:41am
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Feb 1, 2024 11:30am